PETRICHOR SCION THERAPEUTICS — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Syntimmune, Inc.Jun 2017SEC filingmedium confidence
New York, US
Board seatAaron Kantoff· per SEC Form D · $50M raise · filed Jun 2017
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.